Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension

Inclusion Criteria: * Stable angina I-III class by the Canadian Cardiovascular Society Classification and concomitant primary hypertension * Subject is on beta-blockers treatment for at least 2 months prior to inclusion into survey, with no dose change for a minimum of 4 weeks Exclusion Criteria: * Use of phenylalkylamine and benzothiazepine calcium channel blockers * Hemodynamic significant mitral and aortic valve disease * Acute myocardial infarction and unstable angina within 3 months before enrolment